TADALAFILO PODRÍA SER UNA OPCIÓN TERAPÉUTICA EN LA ENFERMEDAD DE MÉNIÈRE.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Alternate Title:
      Tadalafil could be a therapeutic option in Ménière's disease.
    • Subject Terms:
      MENIERE'S disease; HEARING disorders; SENSORINEURAL hearing loss; BENIGN prostatic hyperplasia; TADALAFIL; VERTIGO; TINNITUS
    • Abstract:
      El artículo discute la posibilidad de utilizar el tadalafilo como opción terapéutica en la enfermedad de Ménière, un trastorno crónico que causa vértigo, acúfenos, plenitud ótica e hipoacusia neurosensorial fluctuante. Aunque no hay estudios que respalden su uso, se presenta un caso clínico en el que un paciente experimentó una remisión total de los síntomas vestibulares después de tomar tadalafilo para tratar la hiperplasia prostática benigna. Sin embargo, se advierte que el tadalafilo puede estar asociado con trastornos auditivos y se recomienda buscar atención médica en caso de disminución o pérdida súbita de la audición. El documento "Manejo del Síndrome Vestibular Agudo" es un capítulo del libro "Ed Akadia" que fue publicado en 2017 y se centra en el manejo de este síndrome. [Extracted from the article]
    • Abstract:
      The article discusses the possibility of using tadalafil as a therapeutic option in Ménière's disease, a chronic disorder that causes vertigo, tinnitus, otic fullness, and fluctuating sensorineural hearing loss. Although there are no studies supporting its use, a clinical case is presented in which a patient experienced complete remission of vestibular symptoms after taking tadalafil to treat benign prostatic hyperplasia. However, it is warned that tadalafil may be associated with auditory disorders and it is recommended to seek medical attention in case of sudden decrease or loss of hearing. The document "Management of Acute Vestibular Syndrome" is a chapter from the book "Ed Akadia" published in 2017 and focuses on the management of this syndrome. [Extracted from the article]
    • Abstract:
      Copyright of Revista ORL is the property of Revista ORL and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)